Oppenheimer Remains Bullish as comScore (SCOR) Files 8-K
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
After-Hours Stock Movers 09/15: (SCOR) (CAR) (P) Higher; (NVAX) (DB) (ORCL) Lower (more...)
September 15, 2016 7:16 PM EDTToday's After-Hours Movers:
Novavax, Inc., (Nasdaq: NVAX) 83% LOWER; announced topline data from two clinical trials of its RSV F-protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) in older adults. The Resolve trial, a Phase 3 trial of our RSV F Vaccine in 11,856 older adults (60 years of age and older), did not meet the pre-specified primary or the secondary efficacy objectives, and did not demonstrate vaccine efficacy.... More
comScore (SCOR) Anticipates Impacts of Misstatements
September 15, 2016 5:40 PM EDTcomScore (NASDAQ: SCOR) disclosed in an SEC filing:
Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim ReviewAs previously disclosed, on February 19, 2016 the Audit Committee (the Audit Committee) of the Board of Directors (the Board) of comScore, Inc. (the Company)... More